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1. Introduction 
Anthracycline antibiotics are widely used in 
human cancer chemotherapy. Their activity has been 
attributed mainly to their intercalation between the 
base pairs of native DNA. In the last few years, how- 
ever, a number of authors have attributed their tyro- 
toxic action to DNA damage, such as single strand 
breaks or alkaline labile regions. Using neutral and 
alkaline sucrose gradient ceatrifugation [ 1 ] or hydroxy- 
apatite column chromatography at 60°C [2], it was 
shown that doxorubicin eeds the cellular environ- 
meat to induce DNA single-strand breaks. By use of 
alkaline sucrose-gradient centrifugation [3], doxo- 
rubicin was shown to induce both single- and double- 
strand breaks. Doxorubicin and daunorubicin duce 
the formation of regions in nuclear DNA which can 
be susceptible to hydrolysis by Neurospora crassa 
endonuclease and which can be demonstrated by
change in the sedimentation properties of nuclear DNA 
in neutral sucrose gradients [4]. Doxorubicin [5], 
daunorubicin [5,6] and aclacinomycin A [7] induce 
single strand scissions in the presence of reducing 
agents. Both free radical of anthracycline quinones and 
hydroxyl radical may react with DNA strands. 
The in vivo effects of anthracycline upon the integ- 
rity of DNA has been studied using cell lysates or 
nuclear structures of various kinds of cells: human 
lymphoblastic cells [1 ], leukemia cells [2], HeLa, 
L~21o leukemia nd Me-180 cells and a rat excision 
repair-deficient line [3] and mouse fibroblasts [4]. in 
[5-7] DNA cleavage was followed with a superhellcal 
DNA. In [8] no degradation of Ehrlich ascites tumor 
cell DNA was shown by treatment of the animals 
with daunorubicin or doxorubicin, contrary to the 
damage observed with L12~o tumor cells. Results 
obtained with one population of tumor cells, in our 
case Ehrllch ascites tumor cells, cannot be applied to 
another kind of cells. For example, using leukemia 
cells from several patients, DNA damages were dif- 
ferent depending on the population of cells [9] when 
uptake and retention of the drug are characteristic of
each drug and uniform for the different cell popula- 
tion. 
Here, we report he results obtained with dauno- 
rubicin and some of its derivatives after administra- 
tion of the drugs to mice bearing an Ehrlich ascites 
tumor. The use of a technique based on the isopycnic 
ceatrifugation f nuclei extracted from Ehrlich ascites 
tumor cells followed by a CsCI gradient allows the 
separation of undegraded DNA [10]. The sedimen- 
tation constant of this DNA has been determined in
an analytical ultracentrifuge, before and after alkaline 
degradation and subsequently the number of single 
strand breaks has been calculated. 
2. Materials and methods 
2.1. Daunorubicin and daunorubicin analogs 
Daunorubicin (DNR), [14-14C] DNR (spec. act. 
50 mCi/mM) and DNR analogs were a generous gift 
from Dr R. Maral (Rh6ne Poulenc SA, Paris). The ana- 
logs are: doxorubicin or adriamycin (DOX), detorubi- 
cin (DETO), daunorubicinol r duborimycin (DOL), 
RP 38422, RP 21080 and its isomers RP 32885, RP 
32886, RP 33366 and N-L-leucyl-daunorubucin 
(LEU-DNR) (table 1). Solutions in saline were prepared 
extemporaneously. 
2.2. Ehrlich ascites tumor {EA T) cells 
CD1 female mice (20-25 g body wt, Charles River) 
were inoculated i.p. with 106 cells/mouse. Resistance 
was developed by treatment with subtherapeutic doses 
of DNR. Eight days after inoculation for sensitive 
Ehrlich ascites tumor (EAT) cells and 15 days for the 
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Table 1 
0 OH 
C&-O 0 OH O-f?, 
Daunorubicm analogs 
Compound 
Daunorubicin 
(RP 13057) DNR 
Doxorubicin 
(RP 25253) DOX 
Daunorubicinol or 
dubor~yc~ (RP 20798) DOL 
Detorubicin 
(RP 33921) DETO 
RP 38422 
RP 210XOa 
RP 32885 
RP 33366 
N-L-Leucyl dauno- 
rubicin (Leu-DNR) 
-CWH,OH 
-CHOH-CH, 
-CO-CH,-0-CO-CH(OC2H5), 
-CO-CH,-S-CH,-COOCH, 
-COCH, 
-COCH, 
-COCH, 
(daunoaomine) 
N”2 
Daunos~~e 
Dauno~ine 
Daunos~~e 
Daunosamine 
I 
c=o 
0 
H 
NH2 
As above 
As above 
L-Leucyl daunosamine 
- - 
a RP 21080 is composed of 4 stereoisomers which have been isolated: the 2 fruns-isomers RP 33365 
and 33366; and the 2 &isomers RP 32885 and 32886 
resistant cells, the ascitic fluid was collected. ‘EAT 
cells were cultured as in [ 111. 
2.3. DNA 
Chicken erythrocyte DNA, highly purified, was 
extracted as in [ 121. Total EAT DNA was extracted 
from EAT cells as in [ 131. Nuclear EAT DNA: The 
nuclear fraction was prepared as in [ 141. The DNA 
was prepared by a method derived from [lo]. The 
nuclear pellet was lysed with 6 M guanidine, viscosity 
was reduced by homogenization with a Dounce homog- 
enizer (Kontes Glass Co., Vineland NJ). Aliquots of 
nuclear lysates were centrifuged (72 h, 30 000 revjmin) 
in a CsCl gradient with a Spinco L 75, using an SW 50.1 
rotor at 20°C. Ten drop fractions were collected. 
2.4. ~~y~icoc~e~ica~ ~e~~o~~ 
The determination of the sedimentation coefficients 
was performed in a Beckman Model E ultracentrifuge, 
equipped with a UV light source and a monochro- 
mator (260 nm) using cells with Epon centerpieces. 
Melting curves were recorded with an UNIC~ 
SP 800, in 0.1 M SSC (15 mM NaCl, 1.5mM trisodium 
citrate). Temperature was increased at 1 ‘C/mm. 
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2 S. Biochemical assays 
DNA and DNR concentrations were determined 
according to [ 111. 
2.6. Estimate of the number of single-strand breaks 
The Mpalues in neutral and alkaline medium were 
estimated from the variation of the sedimentation 
coefficients using the equations in [ 151. 
Neutral medium (1 .O M NaCl): s$, w = 0.0882 MO.346 
I 
Alkaline medium (0.9 M NaCl-0.1 M NaOH): 
s;,, w = 0.0528 i@‘Aoo 
These equations agree well with results relating syow 
to Mw (weight-average molecular weight) [ 161. ’ 
The number of single strand breaks (Sn) can be 
deduced from the relation: 
2 Mn (neutral) -1 
2 Mn (alkaline) 1 
where Mn is the number-average molecular weight 
either in neutral or alkaline medium. For native 
double-helical DNA molecule Mw/Mn has been exper- 
imentally determined and is -2. Therefore, if we use 
the weight-average molecular weights calculated from 
the sedimentation coefficients in neutral and alkaline 
medium, we obtain: 
sw=4 
Mw (neutral) -1 
2 Mw (alkaline) 1 
To obtain comparative values, the number of single 
strand breaks has always been calculated for a DNA 
of M, = 106. 
No single strand breaks can be detected in chicken 
erythrocyte DNA or in EAT DNA. 
3. Results and discussion 
3 .I. Integrity of native DNA molecules in the presence 
of anthracyclines in vitro 
Before starting the study of the postulated forma- 
tion of single-strand breaks in DNA molecules after 
the action of anthracyclines in vivo, it was necessary 
to test the integrity of the DNA molecules after com- 
plexation by anthracyclines in vitro. 
The intercalation of all the tested derivatives 
between the DNA basepairs stabilizes the doubie- 
helical structure of DNA [17-l 91. No single-strand 
breaks can be detected by comparing the sedimenta- 
tion constant of the whole set of compounds measured 
by neutral and alkaline ultracentrifugation (table 2). 
Table 2 
Molecular parameters of the DNA after complexation with daunorubicin or daunorubicin analogs 
Compounds P/D 10 
ATm 
ec> 
SN SA 
P/o 20 
ATm 
(“C) 
SN SA 
Daunorubicin 
Doxorubicin 
Detorubicin 
Daunorubicinol 
RP 21080 
RP 32885 
RP 33,366 
N-L-Leucyl-dauno- 
rubicin 
RI’ 38422a 
8.3 29.2 31.1 
11.0 27.4 34.5 
8.7 27.9 29.2 
- - 
9.0 28.9 
7.6 29.6 
6.4 27.7 
- 
32.2 
28.3 
28.0 
4.2 28.4 30.9 3.2 28.1 31.2 
11.0 17.2 16.2 7.5 18.6 17.5 
5.0 26.4 29.9 
7.6 32.2 31.3 
5.0 28.9 30.6 
7.1 29.2 29.0 
6.1 27.6 30.1 
5.8 28.6 28.4 
6.6 30.1 30.0 
a For RP 38422, another chicken erythrocyte DNA with a lower sedimentation constant has been 
used: SN = 19.2, SA = 17.7; ATm = increase of the melting temperature of DNA, after complexa- 
tion by anthracyclincs; S N = wdimcntation constant in neutral medium (1 M NaCl): SA = sedimenta- 
tion constant in alkaline medium (0.9 M NaCI-0.1 M NaOH): P = DNA concentration; mol nucleo- 
tides/l (mean nucleotide M, 326); D = anthracycline concentration 
Chicken erythrocyte native DNA: T,,. 71°C in 0.1 SSC:SN = 29.S.SA = 30.9 
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20 
10 
2O 
< 
z a 
2O 
10 
--•- =10 , ~  
-•-• =30 ~1 
. . . . . . . . . . . . . . . . . . . . . . . . . . .  
E 
z 
Fraction oF gradient 
Fig.1. Isopycnic separation of the DNA-DNR complex. One 
ml of the nuclear pellet dissolved in 6 M guanidine was added 
to a solution containing 30.72 g CsCI, 0.22 ml 1 M Tris-HCl 
(pH 7.9), 0.02 ml 0.5 M EDTA (pH 7.9) and 22.20 ml H20. 
Aliquots of 5 ml of this final solution were centrifuged at
30 000 rev./min for 72 h at 20°C in ari SW 50.1 rotor. Frac- 
tions of 10 drops were collected: (P) [DNA] in nucleotides/1 
(mean ucleotide M r = 326) ( ); (D) [DNR l ( - - - ) .  
The use of CsCI gradients to extract nuclear DNA 
does not break the anthracycline-DNA complex as 
shown in fig.1 where the absorbance at260 nm of 
DNA and the fluorescence at580 nm of DNR are 
presented. It is easy to see that the two curves can be 
superimposed. 
The CsCI gradient does not induce the formation 
of single-strand breaks in the DNA since the double- 
helical structure ismaintained after gradient centrifu- 
gation and subsequent dialysis of the DNA-DNR 
complex whatever the DNR concentration. No sig- 
nificant changes in the molecular parameters of the 
DNA can be observed (table 3). 
3.2. In rive, influence of some anthracycline drugs on 
the integrity of the DNA from EA T sensitive cells 
The number of single-strand breaks induced in 
EAT nuclear DNA by the various anthracycllnes tested 
as well as the therapeutic efficiency and the intra- 
nuclear localization of the same drugs are given in 
table 4. The number of single-strand breaks is always 
higher than in native DNA or DNA complexed by 
anthracyclines in vitro. 
3.3. Comparison of the in vivo influence of DNR on 
the integrity of DNA molecules from EAT- 
sensitive and -resistant cells 
We compared the number of single-strand breaks 
induced in DNA prepared from nuclei solated from 
sensitive and resistant EAT cells. No significant dif- 
ferences were observed between the results obtained 
with the 2 types of cells prepared from mice after i.p. 
inoculation of DNR at the maximum tolerated ose 
or from EAT cultured cells incubated with DNR. 
In conclusion, if in vitro the binding of the analogs 
of daunorubicin studied here does not induce single- 
strand breaks in the double-helical DNA, it is not the 
same in rive after treatment of mice bearing an Ehrlich 
ascites tumor by the same anthracycline derivatives: 
Table 3 
Molecular parameters of EAT DNA complexed by DNR, before and after CsC1 
gradient centrifugation 
Control P/D = 10 P/D = 20 
A B A B A B 
T m (°C) 72 71.8 81.7 80.8 78.3 78.0 
AT (°C) 5.9 6.1 10.4 8.7 11.1 7.9 
S N 23.2 23.4 24.6 25.3 27.5 25.2 
S A 19.2 19.6 26.9 27.2 29.5 25.8 
sw 0.1 0.1 0.05 0.02 0 0 
P = DNA concentration, mol nucleotides/1 (mean nucleotide M r 326); D = DNR concen- 
tration; A = before CsCI gradient centrffugation; B = after CsC1 gradient centrffugation; 
T m = in 0.1 SSC; A T (o C) = width o f the transition between 17- 83% o f hyperchromicity; 
S N = sedimentation constant in neutral medium (1 M NaC1); S A = sedimentation constant 
in alkaline medium (0.9 M NaC1-0.1 M NaOH); sw = number of single strand breaks/ 
106 DNA M r 
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Table 4 
Number of single strand breaks induced in DNA of EAT cells after treatment ofmice 
by DNR and DNR analogs in vivo 
Drug T m sw Intranuclear d ug a Activity 
(°C) (~g drug/rag protein) (%) 
- 71.5 0.11 (2 )  - - 
Daunombic in  74.9 2.41 (2) 2.40 (4) 180 
Doxorubicin 76.6 0.68 (3) 1.96 (2) 190 
Daunorubicinol 74.6 1.41 (1) 3.83 (2) 160 
Detorubicin 73.1 0.90 (1) 4.10 (2) 190 
RP 38422 71.3 3.76 (2) 0.47 (3) 100 
RP 21080 71.5 0.47 (1) 1.39 (3) 180 
RP 33366 72.0 0.77 (1) 0.59 (3) 140 
RP 32885 - 0.16 (1) 0.72 (3) 190 
RP 32886 - 0.48 (1) 0.27 (1) 176 
Leu-DNR 73.5 1.80 (1) - 163 
a Corrected values taking into account the lysosomal contamination [20] 
Mice were inoculated i.p. with 1 mg drug/mouse and sacrificed after 60 min. Number in 
parentheses: no. expt. T m in 0.1 SSC; sw = number of single strand breaks. Activity is 
expressed by the following ratio: 
Mean survival time (treated mice) 
× 100 
Mean survival time (control) 
Mice are treated at the maximal tolerated dose on days O, I, 2, 3 and 4, the activity is 
significant at > 150% 
the number of single-strand breaks in DNA molecures 
extracted from EAT cells is always higher than in native 
DNA or in DNA complexed in vitro. In all cases, there 
is no correlation between the number of single-strand 
breaks and the therapeutic activity. The antitumor 
activity of the drugs are very different: one of them, 
RP 38422, in spite of an important mutagenic activ- 
ity can be considered as completely devoid of any 
therapeutic effect. RP 21080 is a mixture of 4 stereo- 
isomers, RP 32885, RP 32886, RP 33365 and 
RP 33366. The latter two stereoisomers have a very 
low therapeutic action, but RP 32885 and RP 32886 
have an activity of the same order of magnitude as 
DNR. All the other derivatives are active against 
Ehrlich ascites tumor. Two of these drugs, one active 
(DNR) and one inactive (RP 38422) induce an 
important number of single-strand breaks. But DOX, 
DOL and DETO which have a high therapeutic activ- 
Table 5 
Number of single-strand breaks induced in DNA from EAT-sensitive and -resistant ceils after treatment ofmice or cultured 
cells by DNR 
DNR Sensitive ceils Resistant cells 
r m (°c) , , r  ¢c )  s N s A sw r m (°c) Ar  (°c) s s SA sw 
- 71.5 6.2 16.8 15.1 0.41 71.6 6.9 25.4 22.7 0.21 
11.5 ~g/mouse 71.2 6.1 21.6 13.4 1.46 72.8 6.9 20.6 12.8 1.63 
5 ~g[10 ~ ceils 74.0 10.6 18.6 12.4 1.60 72.4 8.6 19.9 11.5 2.00 
Mice were inoculated i.p. with 11.5 ~g [ 14-14C]DNR/mouse and sacrificed after 60 min. Cells were incubated with 5 gg DNR/ml 
incubation medium and incubation was stopped after 24 h. T m in 0.1 SSC; AT= width of the transition between 17-83% of 
hyperchromicity; S N = sedimentation constant in neutral medium (1 M NaCI); S A = sedimentation constant in alkaline medium 
(0.9 M NaC1-0.1 M NaOH); sw = number of single-strand breaks/106 DNA M r 
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ity induce a lower number of single-strand breaks. 
We have shown that 2-4-t imes less DNR is found 
associated with nuclear DNA in resistant cells [11 ]. 
However, the number of single-strand breaks induced 
in nuclear DNA from resistant cells is of the same 
order of magnitude as the number of single-strand 
breaks in nuclear DNA from sensitive ceils. 
Our results confirm that the anthracyclines need 
the cellular environment to induce single-strand breaks 
in the DNA. The enzymatically formed 'site-specific 
free radicals' postulated in [21] could interact with 
DNA molecules, producing damage to the DNA struc- 
ture. 
One important fact is that no correlation can be 
established between the number of  single-strand 
breaks induced by an anthracycline and its therapeutic 
activity and (or) the quantity of  drug accumulated in
the nuclei. One cannot establish a direct relation 
between the activity of the drug and the integrity of 
the double-helical structure of the DNA molecule. 
Therefore, it is tempting to postulate that, beside the 
intercalation i the DNA molecule, there exists another 
mechanism of  action. 
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